At Harmonic Pharma, we believe that the polypharmacology based technology that we have developed is a powerful way of revisiting safe drugs by de-risking R&D and accelerating delivery to patients.

As our new technology and know-how allow to deliver robust results faster and more cost effectively than in the past, new collaboration models are explored with interested stakeholders.

For instance, it makes it possible for public or private organizations to fund a phase I/II clinical stage that is necessary to get a Proof of Concept in man -for the novel indication identified. With that step validated, the drug can be further developed and marketed by biotech and pharma companies to accelerate patients access to affordable treatments.

If you are interested, please contact us.